Gilead’s Remdesivir supply to be produced by 6 Indian companies

iNDICA NEWS BUREAU- To boost the supply of remdesivir — an experimental drug that has shown promise in treating Covid-19 — its maker, US-based Gilead Sciences, has signed non-exclusive voluntary licensing agreements with at least six Indian pharmaceutical companies. These companies are — Dr. Reddy’s Laboratories Ltd., Zydus Cadila Healthcare Ltd., Biocon company Syngene, Hetero […]